| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Lahousse L, Loth DW, Joos GF, et al. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study[J]. Pulm Pharmacol Ther, 2013, 26(2): 212-217.
|
| 3 |
Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease[J]. Thorax, 2015, 70(1): 33-40.
|
| 4 |
Fatehi Hassanabad A. Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms[J]. Transl Lung Cancer Res, 2019, 8(5):692-699.
|
| 5 |
Young RP, Hopkins RJ. The mevalonate pathway and innate immune hyperresponsiveness in the pathogenesis of COPD and Lung cancer: potential for chemoprevention[J]. Curr Mol Pharmacol, 2017, 10: 46-59.
|
| 6 |
Lam DC, Luo SY, Fu KH, et al. Nicotinic acetylcholine receptor expression in human airway correlates with lung function[J]. Am J Physiol Lung Cell Mol Physiol, 2016, 310: L232-L239.
|
| 7 |
Hopkins RJ, Young RP. Mevalonate signaling, COPD and cancer: the statins and beyond[J]. J Investig Med, 2019, 67(4): 711-714.
|
| 8 |
Walsh A, Perrem L, Khashan AS, et al. Statins versus placebo for people with chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2019, 7: CD011959.
|
| 9 |
Lu Y, Chang R, Yao J, et al. Effectiveness of long-term using statins in COPD-a network meta-analysis[J]. Respir Res, 2019, 20(1): 17.
|
| 10 |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summary[J]. Am J Respir Crit Care Med, 2017, 195: 557-582.
|
| 11 |
Zhang W, Zhang Y, Li CW, et al. Effect of statins on chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials[J]. Chest, 2017, 152(6): 1159-1168.
|
| 12 |
Thomson NC. Clinical Studies of Statins in Asthma and COPD[J]. Curr Mol Pharmacol, 2017, 10(1): 60-71.
|
| 13 |
Su VY, Yang YH, Perng DW, et al. Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap[J]. Aging (Albany NY), 2019, 11(11): 3650-3667.
|
| 14 |
Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease[J]. Am J Respi Crit Care Med, 2005, 172: 189-194.
|
| 15 |
Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure[J]. Chest, 1995, 107: 1193-1198.
|
| 16 |
Katsiki N, Wierzbicki AS, Mikhailidis DP. Pulmonary arterial hypertension and statins: an update[J]. Curr Opin Cardiol, 2011, 26: 322,326.
|
| 17 |
Wang G, Shang W, Ren Y, et al. Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis[J]. Eur J Intern Med, 2019, 70: 39-42.
|
| 18 |
Houghton AM. Mechanistic links between COPD and lung cancer[J]. Nat Rev Cancer, 2013, 13(4): 233-245.
|
| 19 |
Young RP, Hopkins RJ. The mevalonate pathway and innate immune hyper responsiveness in the pathogenesis of COPD and Lung cancer: potential for chemoprevention[J]. Curr Mol Pharmacol, 2017, 10: 46-59.
|
| 20 |
Ridker PM, MacFadyen JG, Thuren T, et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial[J]. Lancet , 2017, 390: 1833-1842.
|
| 21 |
Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study[J]. J Natl Cancer Inst, 2011, 103: 1461-1468.
|
| 22 |
Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer related mortality[J]. N Engl J Med, 2012, 367: 1792-1802.
|
| 23 |
Chen YF, Li XL, Zhang R, et al. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies[J]. Pharmacol Res, 2019, 141: 357-365.
|
| 24 |
Xia DK, Hu ZG, Tian YF, et al. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials[J]. Drug Des Devel Ther, 2019, 13: 405-422.
|